Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1199)	6/3/2002 10:55:52 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

One of the founding themes for the T/FIF threads, biotech in the summer (from today's BioCentury, thanks R.!)....... In the past three summer sessions – the period between Memorial Day and Labor Day in the U.S. (the last Monday in May to the first Monday in September) – the BioCentury index has easily outperformed the NASDAQ Composite. Not that three years make a trend, but the positives are worth noting. Last summer – a particularly dour season for equities – drove all the major market indices down. But the NASDAQ fell 20%, compared to a 14% decline in the BC100. In 2000, the NASDAQ’s 32% upswing was eclipsed by a 67.2% move in the biotech index. And in 1999, the BC100 moved up 36.8%, more than double the 15.1% move by the NASDAQ.